Comparative study on drug policies of BRICs and its implications to China
10.3969/j.issn.1674-2982.2014.10.003
- VernacularTitle:金砖五国药物政策比较及对我国的启示
- Author:
Qian SHEN
;
Tao ZHANG
;
Lina WU
;
Zhongliang ZHOU
;
Bing LV
;
Guiping XU
;
Yan GAO
;
Shimin YANG
;
Yu FANG
- Publication Type:Journal Article
- Keywords:
BRICs;
National drug policy;
Essential medicine;
Drug availability
- From:
Chinese Journal of Health Policy
2014;(10):11-15
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To compare drug policies in Brazil, Russia, India, China, and South Africa (BRICs), sum-marize the experiences from the process of implementation and provide some suggestions to further improve the national drug policy in China. Methods:National drug polices of BRICs and experiences in the implementation of essential medicine policy were summed up systematically by means of systematic review. Results:Essential medicine policy and popular phar-macy are implemented in Brazil;Pharmaceutical separation system is established in Russia;the mode of essential medicine policy in Delhi is typical in India;Government of South African focuses on procurement and distribution of drugs. Although drug policies of BRICs have their own characteristics, the objective is to increase the public access to low-cost, high-quality drugs. Conclusions:Despite the BRICs have attained some achievements, they still face serious challenges in deep-ening the health care reform. Hence, they need to explore the measures continuingly consisting with their national condi-tions, and learn from the experiences of developed countries to further consolidate and improve the national drug policies.
